Amedisys (AMED) Tops Q2 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Amedisys Reports Second Quarter 2018 Financial Results and Updates 2018 Guidance
July 31, 2018 4:10 PM EDTBATON ROUGE, La., July 31, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2018.
Three Month Periods Ended June 30, 2018 and 2017
Net service revenue increased $36.7Â million to $411.6Â million compared to $374.9Â million in 2017 (1).Net income attributable to Amedisys, Inc. of $33.3Â million compared to $4.5Â million in 2017.Net income attributable to Amedisys, Inc. per diluted share of $0.98 per diluted share compared to $0.13 in 2017.Adjusted Quarterly Results*
Adjusted EBITDA of $49.7Â million compared to $36.1Â million in 2017.Adjusted net service revenue of $413.3Â million compared to... More